{"transactions":[{"id":730139,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":36256,"kind":"person","name":"FRIESON RON","position":1,"cik":"0001890219","reported_name":"FRIESON RON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2026-06-22T20:20:07.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":53600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option to purchase shares of the Issuer's common stock (the \"Stock Option\") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continuous service to the Issuer through such vesting date."}],"balance_after":53600,"derivative":{"exercise_price":1.02,"exercise_date":"2027-06-17","expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":53600},"source":{"system":"sec-edgar","filing":"0001890219-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000189021926000001/primarydocument.xml","form_type":"4"}},{"id":730138,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":36256,"kind":"person","name":"FRIESON RON","position":1,"cik":"0001890219","reported_name":"FRIESON RON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-22T20:20:07.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":35700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units (the \"RSUs\") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the \"2023 Plan\"), as provided by the Issuer's Fifth Amended and Restated Non-Employee Director Compensation Program (the \"Program\"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continuous service to the Issuer through such vesting date."}],"balance_after":165200,"source":{"system":"sec-edgar","filing":"0001890219-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000189021926000001/primarydocument.xml","form_type":"4"}},{"id":1114656,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":36256,"kind":"person","name":"FRIESON RON","position":1,"cik":"0001890219","reported_name":"FRIESON RON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2025-06-11T21:13:57.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":53600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option to purchase shares of the Issuer's common stock (the \"Stock Option\") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer."}],"balance_after":53600,"derivative":{"exercise_price":3.92,"exercise_date":"2026-06-10","expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":53600},"source":{"system":"sec-edgar","filing":"0001562180-25-004718","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218025004718/primarydocument.xml","form_type":"4"}},{"id":1114655,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":36256,"kind":"person","name":"FRIESON RON","position":1,"cik":"0001890219","reported_name":"FRIESON RON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-11T21:13:57.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":35700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units (the \"RSUs\") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the \"2023 Plan\"), as provided by the Issuer's Fourth Amended and Restated Non-Employee Director Compensation Program (the \"Program\"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer."}],"balance_after":129500,"source":{"system":"sec-edgar","filing":"0001562180-25-004718","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218025004718/primarydocument.xml","form_type":"4"}},{"id":1297291,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":36256,"kind":"person","name":"FRIESON RON","position":1,"cik":"0001890219","reported_name":"FRIESON RON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2025-01-22T21:06:17.000Z","date":"2025-01-17","kind":"exercise","planned":false,"acquired":false,"shares":20100,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.45,"exercise_date":"2023-06-08","expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":20100},"source":{"system":"sec-edgar","filing":"0001562180-25-000453","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218025000453/primarydocument.xml","form_type":"4"}},{"id":1297290,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":36256,"kind":"person","name":"FRIESON RON","position":1,"cik":"0001890219","reported_name":"FRIESON RON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-22T21:06:17.000Z","date":"2025-01-17","kind":"exercise","planned":false,"acquired":true,"shares":20100,"price":0.45,"value":9045.0,"ownership":{"direct":true},"balance_after":93800,"source":{"system":"sec-edgar","filing":"0001562180-25-000453","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218025000453/primarydocument.xml","form_type":"4"}},{"id":1484543,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":36256,"kind":"person","name":"FRIESON RON","position":1,"cik":"0001890219","reported_name":"FRIESON RON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2024-06-10T20:19:14.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option to purchase shares of the Issuer's common stock (the \"Stock Option\") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer."}],"balance_after":45000,"derivative":{"exercise_price":1.07,"exercise_date":"2025-06-06","expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001562180-24-004905","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218024004905/primarydocument.xml","form_type":"4"}},{"id":1484542,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":36256,"kind":"person","name":"FRIESON RON","position":1,"cik":"0001890219","reported_name":"FRIESON RON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-10T20:19:14.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units (the \"RSUs\") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the \"2023 Plan\"), as provided by the Issuer's Third Amended and Restated Non-Employee Director Compensation Program (the \"Program\"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer."}],"balance_after":73700,"source":{"system":"sec-edgar","filing":"0001562180-24-004905","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218024004905/primarydocument.xml","form_type":"4"}},{"id":1861864,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":36256,"kind":"person","name":"FRIESON RON","position":1,"cik":"0001890219","reported_name":"FRIESON RON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2023-06-08T20:07:48.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option to purchase shares of the Issuer's common stock (the \"Stock Option\") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer."}],"balance_after":45000,"derivative":{"exercise_price":1.2,"exercise_date":"2024-06-06","expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001562180-23-004958","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218023004958/primarydocument.xml","form_type":"4"}},{"id":1861863,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":36256,"kind":"person","name":"FRIESON RON","position":1,"cik":"0001890219","reported_name":"FRIESON RON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-08T20:07:48.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units (the \"RSUs\") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the \"2023 Plan\"), as provided by the Issuer's Second Amended and Restated Non-Employee Director Compensation Program (the \"Program\"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer."}],"balance_after":43700,"source":{"system":"sec-edgar","filing":"0001562180-23-004958","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218023004958/primarydocument.xml","form_type":"4"}},{"id":2237348,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":36256,"kind":"person","name":"FRIESON RON","position":1,"cik":"0001890219","reported_name":"FRIESON RON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2022-06-09T20:57:15.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":20100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The option to purchase shares of the Issuer's common stock (the \"Stock Option\") was granted by the Issuer pursuant to the 2014 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":20100,"derivative":{"exercise_price":0.45,"exercise_date":"2023-06-08","expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":20100},"source":{"system":"sec-edgar","filing":"0001562180-22-004974","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218022004974/primarydocument.xml","form_type":"4"}},{"id":2237347,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":36256,"kind":"person","name":"FRIESON RON","position":1,"cik":"0001890219","reported_name":"FRIESON RON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-09T20:57:15.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":13700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units (the \"RSUs\") were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended (the \"2014 Plan\"), as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the \"Program\"). The RSUs will vest in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":13700,"source":{"system":"sec-edgar","filing":"0001562180-22-004974","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218022004974/primarydocument.xml","form_type":"4"}},{"id":2525784,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":36256,"kind":"person","name":"FRIESON RON","position":1,"cik":"0001890219","reported_name":"FRIESON RON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2021-11-03T20:47:43.000Z","date":"2021-11-01","kind":"grant","acquired":true,"shares":80200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest over three years: 33 1/3 % of the options will vest on the first anniversary of the grant date and the remaining 66 2/3 % will vest ratably on the first day of each calendar quarter thereafter"}],"balance_after":80200,"derivative":{"exercise_price":3.13,"expiration_date":"2031-11-01","underlying":"Common Stock","underlying_shares":80200},"source":{"system":"sec-edgar","filing":"0001562180-21-006801","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218021006801/primarydocument.xml","form_type":"4"}}]}